As of 12:30 PM on the 24th, Celltrion is trading at 298,000 KRW, up 1.88% from the previous day. This represents a 5.67% increase compared to February 24. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have a tentative net sell of 4,606 shares of Celltrion, while institutions have a net buy of 4,000 shares. Over the past five days, individual investors have net bought 228,371 shares, whereas foreigners and institutions have net sold 157,194 shares and 77,517 shares, respectively.


On March 17, Celltrion was a market issue with the headline '210 billion KRW scale "Truxima" supply contract... stock price in decline.'





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing